Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Dec;56(12):6154-9.
doi: 10.1128/AAC.05654-11. Epub 2012 Sep 17.

Genetic and biochemical characterization of an acquired subgroup B3 metallo-β-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia

Affiliations
Case Reports

Genetic and biochemical characterization of an acquired subgroup B3 metallo-β-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia

Dongeun Yong et al. Antimicrob Agents Chemother. 2012 Dec.

Abstract

Three clinical Pseudomonas aeruginosa isolates (WCH2677, WCH2813, and WCH2837) isolated from the Women's and Children's Hospital, Adelaide, Australia, produced a metallo-β-lactamase (MBL)-positive Etest result. All isolates were PCR negative for known MBL genes. A gene bank was created, and an MBL gene, designated bla(AIM-1), was cloned and fully characterized. The encoded enzyme, AIM-1, is a group B3 MBL that has the highest level of identity to THIN-B and L1. It is chromosomal and flanked by two copies (one intact and one truncated) of an ISCR element, ISCR15. Southern hybridization studies indicated the movement of both ISCR15 and bla(AIM-1) within the three different clinical isolates. AIM-1 hydrolyzes most β-lactams, with the exception of aztreonam and, to a lesser extent, ceftazidime; however, it possesses significantly higher k(cat) values for cefepime and carbapenems than most other MBLs. AIM-1 was the first mobile group B3 enzyme detected and signals further problems for already beleaguered antimicrobial regimes to treat serious P. aeruginosa and other Gram-negative infections.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Evidence of movement of ISCR15 and blaAIM-1, and relatedness of AIM-1-positive strains. All panels a marker (lane M), WCH2677 (lane 1), WCH2813 (lane 2), and WCH2837 (lane 3). (A) SpeI digestion. (B) I-CeuI digestion. (C) S1 digestion and probing with blaAIM-1. (D) SpeI digestion and probing with ISCR15.
Fig 2
Fig 2
Alignment of the amino acid sequence of AIM-1 with those of L1 and THIN-B. Differences in the amino acid sequences are noted by a single letter representing the amino acid change within a particular sequence. Conserved residues and residues involved in the coordination of the zinc ions are denoted with asterisks. Numbering is according to the updated BBL scheme (11).
Fig 3
Fig 3
Schematic representation of WCH2677 carrying blaAIM-1 (the arrows in the gene boxes indicate the direction of transcription). The sequence upstream of blaAIM-1 and the oriIS for ISCR1, ISCR3, ISCR5, and IS1294 is highlighted. The putative ribosomal binding site is underlined, and the start codon of blaAIM-1 is indicated in boldface type. GenBank accession numbers are in parentheses.

References

    1. Bellais S, Aubert D, Naas T, Nordmann P. 2000. Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum. Antimicrob. Agents Chemother. 44:1878–1886 - PMC - PubMed
    1. Boschi L, et al. 2000. The Legionella (Fluoribacter) gormanii metallo-beta-lactamase: a new member of the highly divergent lineage of molecular-subclass B3 beta-lactamases. Antimicrob. Agents Chemother. 44:1538–1543 - PMC - PubMed
    1. Bush K. 2010. Alarming beta-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol. 13:558–564 - PubMed
    1. Bush K. 2010. Bench-to-bedside review: the role of beta-lactamases in antibiotic-resistant Gram-negative infections. Crit. Care 14:224 doi:10.1186/cc8892 - DOI - PMC - PubMed
    1. Bush K, Fisher JF. 2011. Epidemiological expansion, structural studies and clinical challenges of new beta-lactamases from Gram-negative bacteria. Annu. Rev. Microbiol. 65:455–478 - PubMed

Publication types

MeSH terms

LinkOut - more resources